Sotera Health Co at JPMorgan Healthcare Conference Transcript
All right. Hello, everybody. Thanks for joining us today. My name is Casey Woodring from the Life Science Tools and Diagnostics team here at JPMorgan. I'm pleased to be joined here today by Sotera Health CEO, Michael Petras, is here to my left. There will be a Q&A portion following the company presentation. So with that, Michael.
Great. Thanks, Casey, and good afternoon, everybody. Thanks for joining us. We'll get through forward-looking statements. Some of the statements I'll make today may be considered forward-looking statements. Please refer to our SEC filings for a description of the risks and uncertainties that could cause our actual results to differ materially from projected or implied.
The company assumes no obligation to update forward-looking statements. During the discussion today, we may talk about certain non-GAAP financial measures, including adjusted EBITDA. And you can refer to our SEC
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |